| 标题 |
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Sylvie Bonvalot; Piotr Lukasz Rutkowski; Juliette Thariat; Sébastien Carrère; Anne Ducassou; et al 出版日期:2019-07-08 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)